Literature DB >> 19436417

Prenatal and postnatal diagnosis of infant disability: breaking the news to mothers.

Joyce A Wright1.   

Abstract

The birth of an infant with a disability is often perceived as the loss of a "perfect" baby and is typically an unanticipated event for the mother and family. Mothers may experience self-blame for the disability; therefore, sensitive communication is crucial. A private setting is recommended, with a minimum of health-care professionals in attendance when the diagnosis is revealed. The perinatal educator can guide the mother through the early emotional phases of processing and accepting the new information by offering support and incorporating timely information and interventions. The perinatal educator can also inform and prepare other expectant couples in the childbirth class and encourage them to support the mother and father in celebrating the forthcoming birth. The objective of nursing care for a mother whose infant is newly diagnosed with a disability is to facilitate a positive outcome for her and to promote optimal infant bonding. In all communication and information, replacing the term "disabled infant" with "infant with a disability" is emphasized in order to recognize the infant first and the disability second.

Entities:  

Keywords:  infant with a disability; informing parents; postnatal diagnosis; prenatal diagnosis

Year:  2008        PMID: 19436417      PMCID: PMC2517190          DOI: 10.1624/105812408X324543

Source DB:  PubMed          Journal:  J Perinat Educ        ISSN: 1058-1243


  2 in total

1.  Mothers of children with Down syndrome reflect on their postnatal support.

Authors:  Brian Skotko
Journal:  Pediatrics       Date:  2005-01       Impact factor: 7.124

2.  Meeting the needs of parents around the time of diagnosis of disability among their children: evaluation of a novel program for information, support, and liaison by key workers.

Authors:  Jugnoo S Rahi; Irene Manaras; Helena Tuomainen; Gillian Lewando Hundt
Journal:  Pediatrics       Date:  2004-10       Impact factor: 7.124

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.